Literature DB >> 15163306

FSH and LH serum/tumor fluid ratios and malignant tumors of the ovary.

I Rzepka-Górska1, A Chudecka-Głaz, B Kosmowska.   

Abstract

The aim of this work was to compare mean concentrations of gonadotropins in serum and fluid from malignant and benign ovarian tumors. We enrolled 126 patients diagnosed with malignant epithelial tumors (n=40), borderline epithelial tumors (n=14), benign cystadenomas (n=28) and simple cysts (n=44) of the ovary. Premenopausal and postmenopausal subgroups were formed in each group. The concentration of FSH and LH was measured in serum and tumor fluid and the serum/tumor fluid ratio was calculated. The results in each group were compared and the sensitivity, specificity, positive and negative predictive values were determined. Mean concentrations of both gonadotropins in ovarian cancer fluid were significantly higher than in the remaining groups (P ranged from <0.005 to <0.0001). Mean serum/fluid ratios were lowest in ovarian cancer (FSH=2.91, LH=4.19). Our findings support the hypothesis that gonadotropins are involved in ovarian carcinogenesis and suggest that gonadotropin serum/tumor fluid ratios could be of value in the differential diagnosis of functional and organic cysts of the ovary. Copyright 2004 Society for Endocrinology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163306     DOI: 10.1677/erc.0.0110315

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  5 in total

1.  Luteinizing hormone compromises the in vivo anti-tumor effect of cisplatin on human epithelial ovarian cancer cells.

Authors:  Yan Huang; Yuqi Zhou; Lingfang Xia; Jia Tang; Hao Wen; Meiqin Zhang
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

Review 2.  Hormone therapy for ovarian cancer: Emphasis on mechanisms and applications (Review).

Authors:  Hongyi Li; Yu Liu; Yang Wang; Xia Zhao; Xiaorong Qi
Journal:  Oncol Rep       Date:  2021-08-26       Impact factor: 3.906

3.  Analysis of Prediagnostic Circulating Levels of Gonadotropins and Androgens with Risk of Epithelial Ovarian Cancer.

Authors:  Deepak Parchwani; Sagar Jayantilal Dholariya; Sohil Takodara; Ragini Singh; Vivek Kumar Sharma; Alpana Saxena; Digishaben D Patel; Madhuri Radadiya
Journal:  J Lab Physicians       Date:  2022-01-18

4.  FSH stimulates expression of the embryonic gene HMGA2 by downregulating let-7 in normal fimbrial epithelial cells of ovarian high-grade serous carcinomas.

Authors:  Xu-Yin Zhang; Jing-Xin Ding; Xiang Tao; Ke-Qin Hua
Journal:  Exp Ther Med       Date:  2012-02-11       Impact factor: 2.447

5.  Follicle-Stimulating Hormone Is an Autocrine Regulator of the Ovarian Cancer Metastatic Niche Through Notch Signaling.

Authors:  Sakshi Gera; Sandeep Kumar S; Shalini N Swamy; Rahul Bhagat; Annapurna Vadaparty; Ramesh Gawari; Ramray Bhat; Rajan R Dighe
Journal:  J Endocr Soc       Date:  2018-12-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.